Due to a lack of sterility assurance, the FDA has issued a warning not to use any sterile drug products—including bevacizumab (Avastin)—produced by Pacifico National Inc, doing business as AmEx Pharmacy in Melbourne, Florida. Source: AAO
Investigators evaluated a water-free cyclosporine formulation (CyclASol) for moderate to severe dry eye disease. Source: AAO
Investigators report outcomes of wavefront-guided photorefractive keratectomy (WG-PRK) for high astigmatism after keratoplasty. Source: AAO
This week, Orion’s visual prosthesis gives the Argus II a run for its money, a Brazilian startup presents an affordable and portable ophthalmoscope and an international team eradicates Botswana’s backlog of 6,000 cataract blindness cases. Source: AAO
This study compared the incidence of intraoperative floppy-iris syndrome (IFIS) in male and female patients undergoing cataract surgery. Source: AAO
AbbVie has agreed to acquire Allergan for $63 billion, unlocking key opportunities for growth on both sides of the deal. Source: AAO
Investigators explored the incidence of and risk factors for developing persistent low-pressure syndrome after lumbar puncture (LP) in patients with idiopathic intracranial hypertension (IIH). Source: AAO
This prospective study investigated the efficacy and safety of pembrolizumab as a first-line therapy for metastatic uveal melanoma. Source: AAO
Investigators of this multicenter study evaluated long-term outcomes of a progressively enlarging prosthesis with dermis fat grafting for congenital anophthalmia. Source: AAO
This week, a geneticist unveils the world’s first keratoconus mouse, an ophthalmology researcher with vision loss advocates for an inclusive workforce and new findings challenge the benefits of complement inhibitors in retinal degeneration. Source: AAO